Indomethacin and retinopathy of prematurity: The hidden paradox

Journal of Pediatrics

Volumn 153, Issue 4, 2008, Pages 587-588

  Hammerman, Cathy ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

DRUG MEGADOSE; HUMAN; HYPOXIA; INCIDENCE; LETTER; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; RISK FACTOR; VASOCONSTRICTION;

DUCTUS ARTERIOSUS, PATENT; HUMANS; INDOMETHACIN; INFANT, NEWBORN; RETINOPATHY OF PREMATURITY; VASOCONSTRICTION;

EID: 51449084732     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.05.009     Document Type: Letter

References (8)

1. Jegatheesan P., Ianus V., Buchh B., Yoon G., Chorne N., Esing A., et al. Increased indomethacin dosing for persistent patent ductus arteriosus in pretrerm infants: a multicenter, randomized, controlled trial. J Pediatr 153 (2008) 183-189
2. Parys-Van Ginderdeuren R., Malcolm D., Varma D.R., Aranda J.V., and Chemtob S. Dissociation between prostaglandin levels and blood flow to the retina and choroid in the newborn pig after nonsteroidal antiinflammatory drugs. Invest Ophthalmol Vis Sci 33 (1992) 3378-3384
3. Knight D.B. The treatment of patent ductus arteriosus in preterm infants: a review and overview of randomized trials. Semin Neonatol 6 (2001) 63-73
4. Herrera C., Holberton J., and Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (2007) CD003480
5. Malviya M., Ohlsson A., and Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (2008) CD003951
6. Nandgaonkar B.N., Rotschild T., Yu K., and Higgins R.D. Indomethacin improves oxygen-induced retinopathy in the mouse. Pediatr Res 46 (1999) 184-188
7. Abran D., Varma D.R., and Chemtob S. Increased thromboxane-mediated contractions of retinal vessels of newborn pigs to peroxides. Am J Physiol 268 (1995) H628-H632
8. Avila-Vazquez M., Maffrand R., Sosa M., Franco M., Alvarez B., Cafferata M.L., et al. Treatment of retinopathy of prematurity with topical ketorolac tromethamine: a preliminary study. BMC Pediatr 4 (2004) 15-21